FDA Announces Approval of Information Collection for Drug and Biologic Advertisements

Summary

The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) to collect information related to advertisements and promotional labeling for drugs and biologics intended for human use, as required by the Paperwork Reduction Act of 1995.